Vimeo
LinkedIn
Instagram
Share |

investment

April 5, 2022

In this week’s FB Roundup, Elon Musk obtains a 9.2% stake in Twitter; Henry Sy’s family buy out Philippine Geothermal Production Co; and The Rockefeller Foundation makes a $105 million climate-friendly food pledge.

Elon Musk obtains 9.2% Twitter stake for $2.89 billion
Shares in social media titan Twitter have swollen by 25% after the world’s richest person Elon Musk [pictured left] bought a 9.2% stake for $2.89 billion.

The Tesla and SpaceX founder snapped up 73,486,938 Twitter shares in a move that has surprised many, particularly as Musk has been critical of the channel’s free-speech policies.

April 4, 2022

The Russia-Ukraine war adds to near-term growth risks for the global economy and will likely keep inflation elevated for longer. While uncertainty is high, equity markets are oversold and should recover if tensions ease in the coming months says Russell Investments’ global head of investment strategy Andrew Pease.

The Russia-Ukraine war adds to near-term growth risks for the global economy and will likely keep inflation elevated for longer. While uncertainty is high, equity markets are oversold and should recover if tensions ease in the coming months says Russell Investments’ global head of investment strategy Andrew Pease.


Key market themes

April 4, 2022

China’s bid for global power, climate change and the transition away from fossil fuels are three of the defining megatrends of our time. Collectively, they promise generational upheaval. But decades of peace and stability have left markets, politics, economies and societies complacent and vulnerable. It’s going to get bumpy says Ruffer LLP investment director Alexander Chartres.

China’s bid for global power, climate change and the transition away from fossil fuels are three of the defining megatrends of our time. Collectively, they promise generational upheaval. But decades of peace and stability have left markets, politics, economies and societies complacent and vulnerable. It’s going to get bumpy says Ruffer LLP investment director Alexander Chartres.

Note: This article was written in late 2021, before the Russian invasion of Ukraine.

March 31, 2022

Medtech company Edinburgh Biosciences (EBS) is working towards a global solution for the diagnosis and treatment of cataracts. Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum, chief executive officer Dr Graham Bell, explains the benefits and potential future applications of the technology.

Medtech company Edinburgh Biosciences (EBS) is working towards a global solution for the diagnosis and treatment of cataracts. Using a new light-based non-surgical treatment, this cutting-edge treatment has already proved effective in clinical trials.

Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum on June 6 and 7, Edinburgh Biosciences’ chief executive officer Dr Graham Bell, explains the benefits and potential future applications of the technology.

March 24, 2022

inHEART is pioneering precise digital maps in a process that could revolutionise cardiac care. Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum on June 6 and 7, president and chief executive officer Todor Jeliaskov explains the benefits and potential future applications of the platform.

inHEART is pioneering precise digital maps in a process that could revolutionise cardiac care. Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum on June 6 and 7, president and chief executive officer Todor Jeliaskov explains the benefits and potential future applications of the platform.

March 21, 2022

Implementing a successful private markets program as part of a total portfolio is not without some implementation challenges, says Russell Investments’ alternative investments client portfolio manager Darren Spencer, and perhaps the most pressing issue investors face which needs to be solved for is managing the J-curve.

March 17, 2022

Inflation is running hot, even before wage-price pressures have begun says Ruffer LLP economist Jamie Dannhauser.

Inflation is running hot, even before wage-price pressures have begun says Ruffer LLP economist Jamie Dannhauser.

Central bankers tell us the current burst of inflation will be transitory and workers will not mind the temporary squeeze on their living standards.

In today’s full employment economy, this is not convincing. The implied policy response is flawed, potentially even reckless.

March 17, 2022

In this week’s FB Roundup, property developer Nick Candy enlists a football legend for his Chelsea takeover bid; Sheikh Abdul Aziz Al Khalifa buys a stake in an ethical fintech startup; and Dr. Kiran Patel expands his investment into electric vehicles.

Nick Candy enlists football icon Gianluca Vialli in Chelsea takeover bid

British luxury property developer Nick Candy has further bolstered his bid to buy embattled Premier League football club Chelsea by hiring the team’s former player-manager Gianluca Vialli as an advisor.

Candy, who, along with his brother Christian, has overseen such notable projects as London’s One Hyde Park and NoHo Square and Beverly Hills’s 9900 Wilshire, brought Vialli’s Tifosy Capital & Advisory on board ahead of the deadline for bids.

March 10, 2022

Companies developing robotic assistance for spine surgery, innovative treatment of cataracts, 3D cardiac modelling software, extracorporeal respiratory support systems and therapy for glaucoma surgery scar prophylaxis will exclusively present in-person as Campden Wealth returns to Lausanne, Switzerland, for the 32nd edition of the MedTech Investing Forum on June 6 and 7.

Companies developing robotic assistance for spine surgery, innovative treatment of cataracts, 3D cardiac modelling software, extracorporeal respiratory support systems and therapy for glaucoma surgery scar prophylaxis will exclusively present in-person as Campden Wealth returns to Lausanne, Switzerland, for the 32nd edition of the MedTech Investing Forum on June 6 and 7.

Click here >>
Close